Indium In-111 Pentetreotide and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Indium In-111 Pentetreotide and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetreotide in-111
Brand name: OctreoScan
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium In-111 Pentetreotide-Insulin glargine, recombinant Subcutaneous
- Indium In-111 Pentetreotide-Insulin glulisine
- Indium In-111 Pentetreotide-Insulin Glulisine (Cartridges and Pens)
- Indium In-111 Pentetreotide-Insulin Glulisine (Vials)
- Indium In-111 Pentetreotide-Insulin glulisine Subcutaneous
- Indium In-111 Pentetreotide-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indium Oxyquinoline
- Insulin glargine and lixisenatide Subcutaneous-Indocid
- Insulin glargine and lixisenatide Subcutaneous-Indocin
- Insulin glargine and lixisenatide Subcutaneous-Indocin (Indomethacin Suppositories)
- Insulin glargine and lixisenatide Subcutaneous-Indocin (Indomethacin Suspension)
- Insulin glargine and lixisenatide Subcutaneous-Indocin Injection